Trial intelligence / Profile preview

Deep vs Moderate Block on Stress Response in Gastrectomy

NCT02100280Phase 4Completed

Sponsor
Seoul National University Bundang Hospital
Start
Jun 2014
Primary completion
Jun 2017
Modality
Biodegradable Polymers, Small Molecules
01

Overview

A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Seoul National University Bundang Hospital. Started Jun 2014; status: completed.

02

Drugs

Sugammadex
03

Conditions

neuromuscular blockade (NMB)

Beyond the preview

Go deeper on NCT02100280.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02100280.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call